« Previous
Next »
Psychiatry Research
Volume 151, Issue 1
, Pages 155-157
, 30 May 2007
Blood pressure, heart rate, and anxiety in schizophrenia
References
- . A follow-up study of DSM-III-R generalized anxiety disorder with syndromal and subsyndromal major depression. Journal of Affective Disorders. 2003;73:229–236
- . Loss of efferent vagal activity in acute schizophrenia. Journal of Psychiatric Research. 2005;39:519–527
- . Panic attacks and schizophrenia: assessment and treatment. Psychiatric Annals. 1994;24:473–476
- . Anxiety disorders in major depression. Comprehensive Psychiatry. 2000;41:97–102
- . Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. BMJ. 2004;325:1070
- . Panic disorder in completed suicide. Journal of Clinical Psychiatry. 1996;57:275–281
- . Maladaptive growth in the failing heart: the cardiomyopathy of overload. Cardiovascular Drugs and Therapy. 2002;16:245–249
- . Lifetime prevalence of mood and anxiety disorders in twin pairs discordant for schizophrenia. Twin Research. 2000;3:28–32
- . Impaired fasting glucose tolerance in first-episode, drug-naïve patients with schizophrenia. American Journal of Psychiatry. 2003;160:284–289
- . Risperidone in the treatment of schizophrenia: a meta-analysis of randomized controlled trials. Journal of Psychopharmacology. 1997;11:65–71
- . The influence of psychotic states on the autonomic nervous system in schizophrenia. International Journal of Psychophysiology. 1999;31:147–154
- . Comorbid anxiety disorders and divalproex sodium use among partial hospital patients with psychotic disorders. Comprehensive Psychiatry. 2005;46:368–370
- . Heart rate and QT internal variability: abnormal alpha-2 adrenergic function in patients with panic disorder. Psychiatry Research. 2003;121:185–196
- . Reduced short-term obsessive–compulsive symptoms in schizophrenic patients treated with risperidone: a single-blind prospective study. Human Psychopharmacology. 2003;18:635–640
- . Elevated expression of integrin alpha(IIb) beta(IIIa) in drug-naive, first-episode schizophrenic patients. Biological Psychiatry. 2002;52:874–879
- . Dysregulation of arousal and amygdala-prefrontal systems in paranoid schizophrenia. American Journal of Psychiatry. 2004;161:1–10
- . Neuroleptic effects on autonomic activity in schizophrenia: between-group and within-subject paradigms and comparisons with controls. Schizophrenia Bulletin. 2001;27:503–515
PII: S0165-1781(06)00276-9
doi: 10.1016/j.psychres.2006.09.002
« Previous
Next »
Psychiatry Research
Volume 151, Issue 1
, Pages 155-157
, 30 May 2007
